112 related articles for article (PubMed ID: 1322678)
1. HSV-IgA serum antibodies in cervical intraepithelial neoplasia and invasive cancer patients, and in their spouses: a case control study.
Gupta MM; Jain R; Parashari A; Singh V; Satyanarayana L
APMIS; 1992 Jul; 100(7):598-604. PubMed ID: 1322678
[TBL] [Abstract][Full Text] [Related]
2. Class-specific herpes simplex virus antibodies in sera and cervical secretions from patients with cervical neoplasia: a multi-group comparison.
Dale GE; Coleman RM; Best JM; Benetato BB; Drew NC; Chinn S; Papacosta AO; Nahmias AJ
Epidemiol Infect; 1988 Jun; 100(3):445-65. PubMed ID: 2837405
[TBL] [Abstract][Full Text] [Related]
3. A geographical study of antibodies to membrane antigens of HSV-2-infected cells and HSV-2-specific antibodies in patients with cervical cancer.
Mendis LN; Best JM; Senarath L; Chiphangwi J; Vestergaard BF; Banatvala JE
Int J Cancer; 1981 Nov; 28(5):535-42. PubMed ID: 6273337
[TBL] [Abstract][Full Text] [Related]
4. Serum antibodies to the major HSV-2-specified DNA-binding protein in patients with an acute HSV infection or cervical neoplasia.
Lehtinen M; Lehtinen T; Koivisto V; Paavonen J; Leinikki P
J Med Virol; 1985 Jul; 16(3):245-56. PubMed ID: 2993495
[TBL] [Abstract][Full Text] [Related]
5. A prospective study of the relationship between genital herpes and carcinoma of the uterine cervix. I. Seroepidemiology of herpes simplex virus type 1 and type 2 in women with a previous history of clinically diagnosed genital herpes.
Vestergaard BF
Dev Biol Stand; 1982; 52():95-8. PubMed ID: 6299863
[TBL] [Abstract][Full Text] [Related]
6. A prospective study of association of herpes simplex virus and human papillomavirus infection with cervical neoplasia in women exposed to diethylstilbestrol in utero.
Adam E; Kaufman RH; Adler-Storthz K; Melnick JL; Dreesman GR
Int J Cancer; 1985 Jan; 35(1):19-26. PubMed ID: 2981778
[TBL] [Abstract][Full Text] [Related]
7. Relationship of herpes simplex virus type-2 antibodies and squamous dysplasia to cervical carcinoma in situ.
Thomas DB; Rawls WE
Cancer; 1978 Dec; 42(6):2716-25. PubMed ID: 215294
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for cervical neoplasia in Denmark.
Kjaer SK
APMIS Suppl; 1998; 80():1-41. PubMed ID: 9693662
[TBL] [Abstract][Full Text] [Related]
9. Prospective study on the relationship between cervical neoplasia and herpes simplex type-2 virus. II. Herpes simplex type-2 antibody presence in sera taken at enrollment.
Vonka V; Kanka J; Hirsch I; Závadová H; Krcmár M; Suchánková A; Rezácová D; Broucek J; Press M; Domorázková E
Int J Cancer; 1984 Jan; 33(1):61-6. PubMed ID: 6319297
[TBL] [Abstract][Full Text] [Related]
10. Cervical cancer and herpes simplex virus type 2: case-control studies in Spain and Colombia, with special reference to immunoglobulin-G sub-classes.
Muñoz N; Kato I; Bosch FX; De Sanjosé S; Sundquist VA; Izarzugaza I; Gonzalez LC; Tafur L; Gili M; Viladiu P
Int J Cancer; 1995 Feb; 60(4):438-42. PubMed ID: 7829255
[TBL] [Abstract][Full Text] [Related]
11. Herpes simplex virus. An expanding relationship to human cancer.
Smith JW
J Reprod Med; 1983 Feb; 28(2):116-22. PubMed ID: 6300393
[TBL] [Abstract][Full Text] [Related]
12. Serum IgA antibodies in HSV asymptomatic genital infections.
Guglielmino SP; Garozzo A; Pinizzotto MR; Furneri PM; Corbino N; Castro A; Cianci S
J Med Virol; 1989 Mar; 27(3):210-4. PubMed ID: 2542431
[TBL] [Abstract][Full Text] [Related]
13. Chlamydia trachomatis and cervical neoplasia.
Schachter J; Hill EC; King EB; Heilbron DC; Ray RM; Margolis AJ; Greenwood SA
JAMA; 1982 Nov; 248(17):2134-8. PubMed ID: 6288978
[TBL] [Abstract][Full Text] [Related]
14. Herpes simplex virus-2 as a human papillomavirus cofactor in the etiology of invasive cervical cancer.
Smith JS; Herrero R; Bosetti C; Muñoz N; Bosch FX; Eluf-Neto J; Castellsagué X; Meijer CJ; Van den Brule AJ; Franceschi S; Ashley R;
J Natl Cancer Inst; 2002 Nov; 94(21):1604-13. PubMed ID: 12419786
[TBL] [Abstract][Full Text] [Related]
15. Pre- and posttreatment serum antibody responses to HPV 16 E2 and HSV 2 ICP8 proteins in women with cervical carcinoma.
Lehtinen M; Leminen A; Kuoppala T; Tiikkainen M; Lehtinen T; Lehtovirta P; Punnonen R; Vesterinen E; Paavonen J
J Med Virol; 1992 Jul; 37(3):180-6. PubMed ID: 1331306
[TBL] [Abstract][Full Text] [Related]
16. Chlamydia trachomatis and herpes simplex virus IgA antibodies in cervical secretions of patients with cervical atypia.
Kalimo K; Terho P; Honkonen E; Grönroos M; Halonen P
Br J Obstet Gynaecol; 1981 Nov; 88(11):1130-4. PubMed ID: 6271164
[TBL] [Abstract][Full Text] [Related]
17. Class-specific antibodies (IgG and IgA) to membrane antigens of Herpes simplex type 2-infected cells in patients with cervical dysplasia and neoplasia.
Mendis LN; Best JM; Banatvala JE
Int J Cancer; 1981 May; 27(5):669-77. PubMed ID: 6270022
[No Abstract] [Full Text] [Related]
18. [Seroepidemiological studies related to the association of genital herpes to cervical cancer (author's transl)].
Koenig UD; Haag A; Lehmk
Geburtshilfe Frauenheilkd; 1975 Dec; 35(12):909-13. PubMed ID: 174969
[TBL] [Abstract][Full Text] [Related]
19. Specific IgG and IgA antibodies to herpes simplex virus (HSV)-induced surface antigen in patients with HSV infections and in healthy adults.
Hadar T; Sarov I
J Med Virol; 1984; 14(3):201-7. PubMed ID: 6094720
[TBL] [Abstract][Full Text] [Related]
20. Lack of serum antibodies to the major HSV-2 specified DNA-binding protein before diagnosis of cervical neoplasia.
Lehtinen M; Hakama M; Knekt P; Heinonen PK; Lehtinen T; Paavonen J; Teppo L; Leinikki P
J Med Virol; 1989 Feb; 27(2):131-6. PubMed ID: 2537883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
